This has already proven to be a fertile year for University of Virginia start-up company, ContraVac. The company recently received FDA approval for SpermCheck Vasectomy, a home test that confirms men's post-vasectomy sterility and also received $194,700 in funding from the Commonwealth Technology Research Fund.
Read More >>
T100 Spotlight Archive >> |
|
The T100 Alumni Mentoring Program offers U.Va alumni the opportunity to guide start-up companies that have origins at the University. T100 members provide hands-on mentoring and financial contributions to support companies as they evolve from concept to commercial enterprise. Mentors participate in a monthly conference call to help their team advance the commercial promise of the technology.
JOIN T100 U.Va.-related start-up companies and University alumni are invited to join the T100 Alumni Mentoring Program. Interested alumni are encouraged to inquire about mentorship opportunities. Faculty start-ups should contact us regarding application procedures. Find out more.
T100 COMPANY PRESENTS RESULTS FOR REVERSING TYPE I DIABETES (6.10.08) DiaKine Therapeutics' unique drug therapy, a combination of LSF and INGAP, may soon be tested as a potential therapy for Type 1 diabetes in people.
POCKETMED HONORED FOR NOTEWORTHY CONTRIBUTIONS TO THE MARKETPLACE (5.22.08) The Charlottesville Innovation Awards, hosted by the Charlottesville Business Innovation Council, recognized T100 company, PocketMed, as a finalist for the Rocket Award.
FOUNDER OF T100 COMPANY, PLUROGEN THERAPEUTICS, NAMED U.VA. INVENTOR OF THE YEAR (5.08.08) George Rodeheaver is being recognized for his revolutionary wound-healing technology. His company, PluroGen Therapeutics (a U.Va. start-up and T100 company) is currently seeking FDA approval to make the product commercially available.
U.VA. PATENT FOUNDATION LICENSES SILVER NANOPARTICLE TECHNOLOGY TO U.VA. START-UP PLUROGEN THERAPEUTICS INC. (04.21.08) The new technology will be used as an enhanced anti-microbial agent to fight infection and promote wound-healing.
STATE FUND BACKS U.VA. RESEARCH WITH COMMERCIAL POTENTIAL (03.31.08) John Herr, founder of T100 graduate ContraVac Inc., is the recipient of funding from the Commonwealth Technology Research Fund, designed to accelerate research and commercialization activities across the state.
HOME GUARDIAN RELEASES INNOVATIVE SENSOR SYSTEM TO KEEP SENIORS SAFE (03.27.08)
Home Guardian, LLC has announced the release of a suite of sensors that non-intrusively monitor the health status of seniors in their homes while enabling professional caregivers to provide needed care. This includes the detection of falls, which constitute the largest cause of injuries for people over age 65 in the United States.
READ MORE T100 NEWS
|
